Zealand Pharma to Participate in Upcoming Healthcare Conferences
June 06, 2023 11:00 ET
|
Zealand Pharma
Press release – No. 4 / 2023 Zealand Pharma to Participate in Upcoming Healthcare Conferences Copenhagen, Denmark, June 6, 2023 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078),...
Total number of shares and voting rights in Zealand Pharma at May 31, 2023
May 31, 2023 11:05 ET
|
Zealand Pharma
Company announcement – No. 24 / 2023 Total number of shares and voting rights in Zealand Pharma at May 31, 2023 Copenhagen, Denmark, May 31, 2023 – Zealand Pharma A/S (“Zealand”)...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
May 25, 2023 16:00 ET
|
Zealand Pharma
Company announcement – No. 23 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
May 23, 2023 16:00 ET
|
Zealand Pharma
Company announcement – No. 22 / 2023 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, May 23, 2023 – Zealand Pharma A/S...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
May 12, 2023 15:00 ET
|
Zealand Pharma
Company announcement – No. 21 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
Zealand Pharma Announces Financial Results for the First Quarter of 2023
May 11, 2023 01:00 ET
|
Zealand Pharma
Company announcement - No. 20 / 2023 Zealand Pharma Announces Financial Results for the First Quarter of 2023 Positive topline data from obesity portfolioOn track for two regulatory submissions...
Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight
May 10, 2023 02:30 ET
|
Zealand Pharma
Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight Phase II dose-finding trial met primary endpoint after 46...
Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results
May 04, 2023 11:05 ET
|
Zealand Pharma
Press Release– No. 3 / 2023 Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results Copenhagen, Denmark, May 4, 2023 – a Zealand Pharma A/S...
Total number of shares and voting rights in Zealand Pharma at April 28, 2023
April 28, 2023 11:05 ET
|
Zealand Pharma
Company announcement – No. 18 / 2023 Total number of shares and voting rights in Zealand Pharma at April 28, 2023 Copenhagen, Denmark, April 28, 2023 – Zealand Pharma A/S (“Zealand”)...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
April 25, 2023 13:30 ET
|
Zealand Pharma
Company announcement – No. 17 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...